Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2013-01-31
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
high fat meal without dairy products
high fat meal without dairy products
consumption of high fat test meal without dairy products
high fat meal with additional milk
high fat meal with additional milk
consumption of high fat test meal with dairy products
dairy product meal
dairy product meal
consumption of test meal based on dairy products
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
consumption of test meal based on dairy products
consumption of high fat test meal without dairy products
consumption of high fat test meal with dairy products
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI ≥ 20 kg/m2
* age 25-55 y
* informed consent
Exclusion Criteria
* Allergies to food or intolerance to high-fat meal
* Vegetarians
* Chronic intake of drugs
* Smokers
* Diabetes mellitus Type I and II
* Debilitating kidney diseases
* Debilitating liver diseases
* Clinically established coronary heart diseases
* Ingestion of vitamins or dietary supplements during the course of the study
25 Years
55 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Insel Gruppe AG, University Hospital Bern
OTHER
Agroscope Liebefeld-Posieux Research Station ALP
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guy Vergeres
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kur Laederach, MD
Role: PRINCIPAL_INVESTIGATOR
Insel Gruppe AG, University Hospital Bern
Alexandra Schmid
Role: STUDY_DIRECTOR
Agroscope Liebefeld-Posieux ALP
Caroline Buri, MD, PhD
Role: STUDY_DIRECTOR
Insel Gruppe AG, University Hospital Bern
Guy Vergères, PhD
Role: STUDY_DIRECTOR
Agroscope Liebefeld-Posieux ALP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital, Inselspital Berne
Bern, Canton of Bern, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NUTRICHIP-2
Identifier Type: -
Identifier Source: org_study_id